IDEXX Laboratories (IDXX) Earnings Date, Estimates & Call Transcripts → Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad) Free IDXX Stock Alerts $478.24 -11.33 (-2.31%) (As of 05:27 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 1Before Market OpensConfirmedActual EPS (Feb. 5) $2.32 Beat By $0.20 Consensus EPS (Feb. 5) $2.12 Read Call TranscriptListen to Call Get IDEXX Laboratories Earnings AlertsEnter your email address below to receive the latest news and earnings results for IDXX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIDXX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IDXX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm PressCould Bitcoin Literally FORCE This Crypto To Rocket Up?Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. IDEXX Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$2.55$2.72$2.64 Q2 20242$2.85$2.86$2.86 Q3 20242$2.75$2.78$2.77 Q4 20242$2.77$2.91$2.84 FY 20248$10.92$11.27$11.10 Q1 20252$2.96$3.13$3.05 Q2 20252$3.00$3.26$3.13 Q3 20252$3.13$3.18$3.16 Q4 20251$3.22$3.22$3.22 FY 20257$12.31$12.79 $12.55IDXX Earnings Date and InformationIDEXX Laboratories last released its earnings data on February 5th, 2024. The reported $2.32 earnings per share for the quarter, topping analysts' consensus estimates of $2.12 by $0.20. The business earned $901.60 million during the quarter, compared to the consensus estimate of $891.88 million. Its revenue for the quarter was up 8.8% compared to the same quarter last year. IDEXX Laboratories has generated $10.07 earnings per share over the last year ($10.07 diluted earnings per share) and currently has a price-to-earnings ratio of 47.5. Earnings for IDEXX Laboratories are expected to grow by 14.53% in the coming year, from $11.15 to $12.77 per share. IDEXX Laboratories has confirmed that its next quarterly earnings report will be published on Wednesday, May 1st, 2024. IDEXX Laboratories will be holding an earnings conference call on Wednesday, May 1st at 8:30 AM Eastern. Interested parties can register for or listen to the call.. Read More IDEXX Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/1/2024Confirmed)------- 2/5/2024Q4 2023$2.12$2.32+$0.20$2.32$891.88 million$901.60 million 11/1/2023Q3 2023$2.37$2.53+$0.16$2.53$926.88 million$915.53 million 8/1/2023Q2 2023$2.43$2.67+$0.24$2.67$927.84 million$943.63 million5/2/2023Q1 2023$2.38$2.55+$0.17$2.55$887.36 million$900.20 million2/6/2023Q4 2022$1.92$2.05+$0.13$2.05$820.91 million$828.60 million 11/1/2022Q3 2022$2.04$2.15+$0.11$2.15$829.23 million$841.66 million Get the Latest News and Ratings for IDXX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IDEXX Laboratories and its competitors with MarketBeat's FREE daily newsletter. 8/2/2022Q2 2022$1.54$1.56+$0.02$1.56$864.26 million$860.55 million5/4/2022Q1 2022$2.25$2.27+$0.02$2.27$836.47 million$836.55 million 2/2/2022Q4 2021$1.67$1.89+$0.22$1.89$781.83 million$801.00 million 11/2/2021Q3 2021$1.88$2.03+$0.15$2.03$793.26 million$810.42 million 7/30/2021Q2 2021$2.01$2.34+$0.33$2.34$794.64 million$826.14 million 5/4/2021Q1 2021$1.72$2.35+$0.63$2.35$738.43 million$777.71 million IDEXX Laboratories Earnings - Frequently Asked Questions When is IDEXX Laboratories's earnings date? IDEXX Laboratories has confirmed that its next quarterly earnings data will be published on Wednesday, May 1st, 2024. Learn more on IDXX's earnings history. Did IDEXX Laboratories beat their earnings estimates last quarter? In the previous quarter, IDEXX Laboratories (NASDAQ:IDXX) reported $2.32 earnings per share (EPS) to beat the analysts' consensus estimate of $2.12 by $0.20. Learn more on analysts' earnings estimate vs. IDXX's actual earnings. How can I listen to IDEXX Laboratories's earnings conference call? The conference call for IDEXX Laboratories's latest earnings report can be listened to online. Listen to Conference Call How can I read IDEXX Laboratories's conference call transcript? The conference call transcript for IDEXX Laboratories's latest earnings report can be read online. Read Transcript How much revenue does IDEXX Laboratories generate each year? IDEXX Laboratories (NASDAQ:IDXX) has a recorded annual revenue of $3.66 billion. How much profit does IDEXX Laboratories generate each year? IDEXX Laboratories (NASDAQ:IDXX) has a recorded net income of $845.04 million. IDXX has generated $10.07 earnings per share over the last four quarters. What is IDEXX Laboratories's price-to-earnings ratio? IDEXX Laboratories (NASDAQ:IDXX) has a trailing price-to-earnings ratio of 47.49 and a forward price-to-earnings ratio of 42.89. The price/earnings-to-growth ratio is 3.78. What is IDEXX Laboratories's EPS forecast for next year? IDEXX Laboratories's earnings are expected to grow from $11.15 per share to $12.77 per share in the next year, which is a 14.53% increase. More Earnings Resources from MarketBeat Related Companies: Takeda Pharmaceutical Earnings Date Moderna Earnings Date IQVIA Earnings Date Alcon Earnings Date GE HealthCare Technologies Earnings Date Centene Earnings Date Cencora Earnings Date Humana Earnings Date Haleon Earnings Date Veeva Systems Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff?Dell Technologies breaks out ahead of earnings releaseNovavax’s dispute resolution and upcoming earnings call This page (NASDAQ:IDXX) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchYour Money is Not SafeAmerican AlternativeTop 5 AI Stocks to Buy for 2024Market Moving TrendsOptions trading has suddenly become more reliable.Eagle PublishingTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEXX Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.